Inogen Inc (NAS:INGN)
$ 8.61 0 (0%) Market Cap: 203.00 Mil Enterprise Value: 108.84 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 68/100

Inogen Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 05:00PM GMT
Release Date Price: $47.95 (+2.72%)
Jaypreet Singh Chadha
Morgan Stanley, Research Division - Research Associate

Starting? Excellent. Good afternoon, and thank you all for sticking around on the last in the afternoon. My name is Jay Chadha. I'm part of the medical device research team here at Morgan Stanley. And we have Inogen here with us today. Scott Wilkinson, CEO; and Ali Bauerlein, CFO.

Before we begin, please take a moment to review all applicable disclosures online.

Questions & Answers

Jaypreet Singh Chadha
Morgan Stanley, Research Division - Research Associate

Scott, I thought maybe we could start just with on getting a better sense of the underlying market demand, there have been some challenges earlier this year across the business, and I think what investors are really trying to figure out is how strong is underlying market demand and kind of what have been kind of the puts and takes there.

Scott Wilkinson
Inogen, Inc. - CEO, President & Director

Yes. Thanks. And let me start before I dive into the question, I'd

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot